| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 35 |
| 1 | DARUNAVIR | 32 |
| 2 | ALEMTUZUMAB | 31 |
| 3 | RITONAVIR 100 MG | 29 |
| 4 | DARUNAVIR 600 MG | 23 |
| 5 | DARUNAVIR 800 MG | 23 |
| 6 | ETRAVIRINE | 22 |
| 7 | BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE | 18 |
| 8 | LAMIVUDINE | 13 |
| 9 | LOPINAVIR AND RITONAVIR | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 1 | VALERIAN ROOT, PASSIFLORA, MAGNESIUM CARBONATE | 1 | 0.0054 |
| 2 | ETRAVIRINE | 22 | 0.0050 |
| 3 | EMAPALUMAB-LZSG | 1 | 0.0042 |
| 4 | DARUNAVIR 600 MG | 23 | 0.0037 |
| 5 | DARUNAVIR | 32 | 0.0021 |
| 6 | RITONAVIR 100 MG | 29 | 0.0019 |
| 7 | ALEMTUZUMAB | 31 | 0.0016 |
| 8 | DORAVIRINE | 1 | 0.0013 |
| 9 | CABOTEGRAVIR SODIUM | 2 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon gamma Blocker [EPC] | 1 | 0.0042 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 31 | 0.0016 |
| 2 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 29 | 0.0012 |
| 3 | Protease Inhibitor [EPC] | 45 | 0.0010 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 50 | 0.0008 |
| 5 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 23 | 0.0005 |
| 7 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 49 | 0.0004 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Phosphate Binder [EPC] | 1 | 0.0003 |